| Characteristic | 2019 | 2026 |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
July 2020
Region
Worldwide
Survey time period
as of June 2020
Supplementary notes
Company drug sales from undisclosed products are presumed to be from conventional (small molecule) technology. 2026 values are projected. Companies are ranked by 2026 revenues.
Citation formats









